Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

MYO7A

From Wikipedia, the free encyclopedia
Protein-coding gene in the species Homo sapiens

MYO7A
Available structures
PDBOrtholog search:PDBeRCSB
List of PDB id codes

3PVL

Identifiers
AliasesMYO7A, DFNA11, DFNB2, MYOVIIA, MYU7A, NSRD2, USH1B, myosin VIIA
External IDsOMIM:276903;MGI:104510;HomoloGene:219;GeneCards:MYO7A;OMA:MYO7A - orthologs
Gene location (Human)
Chromosome 11 (human)
Chr.Chromosome 11 (human)[1]
Chromosome 11 (human)
Genomic location for MYO7A
Genomic location for MYO7A
Band11q13.5Start77,128,246bp[1]
End77,215,241bp[1]
Gene location (Mouse)
Chromosome 7 (mouse)
Chr.Chromosome 7 (mouse)[2]
Chromosome 7 (mouse)
Genomic location for MYO7A
Genomic location for MYO7A
Band7 E1|7 53.57 cMStart97,700,267bp[2]
End97,768,731bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • right adrenal cortex

  • left adrenal gland

  • left adrenal cortex

  • left testis

  • right lobe of liver

  • right testis

  • anterior pituitary

  • spleen

  • paraflocculus of cerebellum

  • frontal pole
Top expressed in
  • fourth ventricle

  • choroid plexus of fourth ventricle

  • Ileal epithelium

  • stroma of bone marrow

  • adrenal gland

  • yolk sac

  • retinal pigment epithelium

  • choroidal fissure

  • Epithelium of choroid plexus

  • iris
More reference expression data
BioGPS
n/a
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo /QuickGO
Orthologs
SpeciesHumanMouse
Entrez

4647

17921

Ensembl

ENSG00000137474

ENSMUSG00000030761

UniProt

Q13402

P97479

RefSeq (mRNA)

NM_000260
NM_001127179
NM_001127180
NM_001369365

NM_001256081
NM_001256082
NM_001256083
NM_008663

RefSeq (protein)

NP_000251
NP_001120652
NP_001356294

NP_001243010
NP_001243011
NP_001243012
NP_032689

Location (UCSC)Chr 11: 77.13 – 77.22 MbChr 7: 97.7 – 97.77 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Myosin VIIA isprotein that in humans is encoded by theMYO7Agene.[5] Myosin VIIA is a member of the unconventionalmyosin superfamily of proteins.[6] Myosins areactin binding molecular motors that use the enzymatic conversion of ATP - ADP + inorganic phosphate (Pi) to provide the energy for movement.

Myosins are mechanochemical proteins characterized by the presence of a motor domain, anactin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. Myosin VIIA is an unconventional myosin with the longest tail (1360 aa). The tail is expected to dimerize, resulting in a two-headed molecule. Unconventional myosins have diverse functions ineukaryotic cells and are primarily thought to be involved in the movement or linkage of intra-cellular membranes andorganelles to the actin cytoskeleton via interactions mediated by their highly divergent tail domains.

MYO7A is expressed in a number of mammalian tissues, includingtestis,kidney,lung, inner ear,retina and the ciliatedepithelium of the nasalmucosa.

Clinical significance

[edit]

Mutations in theMYO7A gene cause theUsher syndrome type 1B, a combined deafness/blindness disorder.[6] Affected individuals are typically profoundly deaf at birth and then undergo progressive retinal degeneration.[7]

Model organisms

[edit]
Myo7a mutant mouse phenotype
CharacteristicPhenotype
Homozygote viabilityNormal
FertilityNormal
Body weightAbnormal[8]
AnxietyNormal
Neurological assessmentAbnormal[9]
Grip strengthAbnormal[10]
Hot plateAbnormal[11]
DysmorphologyNormal
Indirect calorimetryAbnormal[12]
Glucose tolerance testAbnormal[13]
Auditory brainstem responseAbnormal
DEXAAbnormal[14]
RadiographyAbnormal[15]
Body temperatureNormal
Eye morphologyNormal
Clinical chemistryAbnormal[16]
PlasmaimmunoglobulinsNormal
HaematologyNormal
Peripheral blood lymphocytesNormal
Micronucleus testNormal
Heart weightNormal
Tail epidermis wholemountNormal
Skin HistopathologyNormal
All tests and analysis from[17][18]

Model organisms have been used in the study of MYO7A function. A spontaneous mutant mouse line, calledMyo7ash1-6J[19] was generated. Male and female animals underwent a standardizedphenotypic screen to determine the effects of deletion.[17][20] Twenty three tests were carried out onmutant mice and ten significant abnormalities were observed.[17] Malehomozygousmutant mice displayed a decreased body weight, a decrease in body fat, improvedglucose tolerance and abnormalpelvic girdle bone morphology. Homozygous mutant mice of both sex displayed various abnormalities in a modifiedSHIRPA test, including abnormal gait, tail dragging and an absence ofpinna reflex, a decrease ingrip strength, an increased thermalpain threshold, severehearing impairment and a number of abnormalindirect calorimetry andclinical chemistry parameters.[17]

References

[edit]
  1. ^abcGRCh38: Ensembl release 89: ENSG00000137474Ensembl, May 2017
  2. ^abcGRCm38: Ensembl release 89: ENSMUSG00000030761Ensembl, May 2017
  3. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^Hasson T, Skowron JF, Gilbert DJ, Avraham KB, Perry WL, Bement WM, Anderson BL, Sherr EH, Chen ZY, Greene LA, Ward DC, Corey DP, Mooseker MS, Copeland NG, Jenkins NA (September 1996)."Mapping of unconventional myosins in mouse and human".Genomics.36 (3):431–9.doi:10.1006/geno.1996.0488.PMID 8884266.
  6. ^abWeil D, Blanchard S, Kaplan J, Guilford P, Gibson F, Walsh J, Mburu P, Varela A, Levilliers J, Weston MD (March 1995). "Defective myosin VIIA gene responsible for Usher syndrome type 1B".Nature.374 (6517):60–1.Bibcode:1995Natur.374...60W.doi:10.1038/374060a0.PMID 7870171.S2CID 4324416.
  7. ^Smith RJ, Berlin CI, Hejtmancik JF, Keats BJ, Kimberling WJ, Lewis RA, Möller CG, Pelias MZ, Tranebjaerg L (March 1994). "Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium".American Journal of Medical Genetics.50 (1):32–8.doi:10.1002/ajmg.1320500107.PMID 8160750.
  8. ^"Body weight data for Myo7a". Wellcome Trust Sanger Institute.
  9. ^"Neurological assessment data for Myo7a". Wellcome Trust Sanger Institute.
  10. ^"Grip strength data for Myo7a". Wellcome Trust Sanger Institute.
  11. ^"Hot plate data for Myo7a". Wellcome Trust Sanger Institute.
  12. ^"Indirect calorimetry data for Myo7a". Wellcome Trust Sanger Institute.
  13. ^"Glucose tolerance test data for Myo7a". Wellcome Trust Sanger Institute.
  14. ^"DEXA data for Myo7a". Wellcome Trust Sanger Institute.
  15. ^"Radiography data for Myo7a". Wellcome Trust Sanger Institute.
  16. ^"Clinical chemistry data for Myo7a". Wellcome Trust Sanger Institute.
  17. ^abcdGerdin AK (2010). "The Sanger Mouse Genetics Programme: High throughput characterisation of knockout mice".Acta Ophthalmologica.88:925–7.doi:10.1111/j.1755-3768.2010.4142.x.S2CID 85911512.
  18. ^Mouse Resources Portal, Wellcome Trust Sanger Institute.
  19. ^"Mouse Genome Informatics".
  20. ^van der Weyden L, White JK, Adams DJ, Logan DW (2011)."The mouse genetics toolkit: revealing function and mechanism".Genome Biology.12 (6): 224.doi:10.1186/gb-2011-12-6-224.PMC 3218837.PMID 21722353.

External links

[edit]

Further reading

[edit]
Human
Microfilaments
andABPs
Myofilament
Actins
Myosins
Other
Other
Intermediate
filaments
Type 1/2
(Keratin,
Cytokeratin)
Epithelial keratins
(soft alpha-keratins)
Hair keratins
(hard alpha-keratins)
Ungrouped alpha
Not alpha
Type 3
Type 4
Type 5
Microtubules
andMAPs
Tubulins
MAPs
Kinesins
Dyneins
Microtubule organising proteins
Microtubule severing proteins
Other
Catenins
Membrane
Other
Nonhuman
Retrieved from "https://en.wikipedia.org/w/index.php?title=MYO7A&oldid=1300843611"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp